(Q44485386)

English

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Michela Cini

2

0 references

Cristina Legnani

object named as

Cristina Legnani

3

0 references

author name string

Benilde Cosmi

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Claudia Pancani

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Fiorella Calanni

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sergio Coccheri

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

333-339

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Treatment of venous leg ulcers with sulodexide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of pharmacodynamics, pharmacokinetics, and therapeutic properties of sulodexide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

IPO-V2: a prospective, multicenter, randomized, comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mobile reactive centre of serpins and the control of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and cellular biology of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparin sequencing brings structure to the function of complex oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The sensitivity of human and bovine thrombin to heparin in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of a new heparin-dependent inhibitor of thrombin in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombin and antithrombotics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological actions of sulodexide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900246-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0049-3848(03)00246-9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44485386&oldid=2025542643"